Acetylsalicylic acid
Author(s)
Bibliographic Information
Acetylsalicylic acid
Wiley-Blackwell, c2009
- : hardback
Available at 1 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and index
Description and Table of Contents
Description
Written by a leading expert on Aspirin-related research, this is the first comprehensive treaty of the history, pharmacological effects and clinical applications of one of the most successful drugs ever. The text is written with a wide audience in mind and to be readily understandable for clinicians as well as biomedical researchers and pharmacologists alike. The content is up to date and includes the latest results of clinical and academic research, with a balanced view on the disputed properties of this famous drug.
Table of Contents
TABLE OF CONTENTS 1. GENERAL ASPECTS 1.1 HISTORY 1.1.1 WILLOW BARK AND LEAVES AS ANTIPYRETIC, ANTI-INFLAMMATORY ANALGESICS 1.1.2 SALICYLATES AS THE ACTIVE INGREDIENT OF WILLOW BARK AND OTHER NATURAL SOURCES 1.1.3 SYNTHESIS OF ACETYLSALICYLIC ACID AND FIRST CLINICAL STUDIES 1.1.4 MODE OF ASPIRIN ACTION 1.1.5 ANTI-INFLAMMATORY/ANALGESIC ACTIONS OF ASPIRIN 1.1.6 ASPIRIN IN THE CARDIOVASCULAR SYSTEM 1.1.7 CURRENT RESEARCH TOPICS 1.2 CHEMISTRY 1.2.1 STRUCTURES AND CHEMICAL PROPERTIES OF SALICYLATES 1.2.2 DETERMINATION OF SALICYLATES 2. PHARMACOLOGY 2.1 PHARMACOKINETICS 2.1.1 ABSORPTION AND DISTRIBUTION 2.1.2 BIOTRANSFORMATION AND EXCRETION 2.2 CELLULAR MODES OF ACTION 2.2.1 INHIBITION OF CYCLOOXYGENASES 2.2.2 COX-INDEPENDENT ACTIONS ON CELL FUNCTION 2.2.3 ENERGY METABOLISM 2.3 ACTIONS ON ORGANS AND TISSUES 2.3.1 HEMOSTASIS AND THROMBOSIS 2.3.2 INFLAMMATION, PAIN AND FEVER 2.3.3 ASPIRIN AND MALIGNANCIES 3. TOXICITY AND DRUG SAFETY 3.1 SYSTEMIC SIDE-EFFECTS 3.1.1 ACUTE AND CHRONIC TOXICITY 3.1.2 BLEEDING DISORDERS 3.1.3 SAFETY PHARMACOLOGY IN PARTICULAR LIFE SITUATIONS 3.2 ORGAN TOXICITY 3.2.1 GASTROINTESTINAL (GI) TRACT 3.2.2 KIDNEY 3.2.3 LIVER 3.2.4 AUDIOVESTIBULAR SYSTEM 3.3 NON-DOSE-RELATED (PSEUDO)ALLERGIC ACTIONS OF ASPIRIN 3.3.1 ASPIRIN HYPERSENSITIVITY (WIDAL'S SYNDROME) 3.3.2 URTICARIA/ANGIOEDEMA, STEVENS-JOHNSON- AND LYELL-SYNDROME 3.3.3 REYE SYNDROME 4. CLINICAL APPLICATIONS OF ASPIRIN 4.1 THROMBOEMBOLIC DISEASES 4.1.1 CORONARY VASCULAR DISEASE 4.1.2 CEREBROVASCULAR DISEASES 4.1.3 PERIPHERAL ARTERIAL DISEASE (PAD) 4.1.4 VENOUS THROMBOSIS 4.1.5 PREECLAMPSIA 4.1.6 ASPIRIN "RESISTANCE" 4.2 PAIN, FEVER AND INFLAMMATORY DISEASES 4.2.1 ASPIRIN AS AN ANTIPYRETIC ANALGESIC 4.2.2 ARTHRITIS AND RHEUMATISM 4.2.3 KAWASAKI DISEASE 4.3 FURTHER CLINICAL INDICATIONS 4.3.1 COLORECTAL CANCER 4.3.2 ALZHEIMER DISEASE ABBREVIATIONS (NO ACRONYMS FOR CLINICAL STUDIES) ACRONYMS FOR CLINICAL STUDIES INDEX TERMS (PRELIMINARY)
by "Nielsen BookData"